dc.creatorLacerda, Marcus Vinicius Guimarães
dc.creatorBonates, Paula
dc.creatorJoão, Guilherme Augusto Pivoto
dc.creatorCruz, Kátia Santana
dc.creatorFerreira, Marcelo de Souza
dc.creatorBaía-da-Silva, Djane Clarys
dc.creatorFarias, Maria Eduarda Leão de
dc.creatorBrito-Sousa, José Diego
dc.creatorSantana, Monique Freire
dc.creatorOliveira, Luciana Aires de
dc.creatorCortez, Ana Cláudia Alves
dc.creatorSouza, João Vicente Braga
dc.date2023-02-06T20:18:27Z
dc.date2023-02-06T20:18:27Z
dc.date2021-06
dc.date.accessioned2023-09-27T00:10:43Z
dc.date.available2023-09-27T00:10:43Z
dc.identifierLACERDA, Marcus Vinicius Guimarães et al. Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19. Revista Sociedade Brasileira de Medicina Tropical, Uberaba, v. 54, p. 1-4, jun. 2021.
dc.identifier0037-8682
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/56902
dc.identifier10.1590/0037-8682-0358-2021
dc.identifier1678-9849
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8898227
dc.descriptionWith the progression of the COVID-19 pandemic, the use of corticosteroids and other immunosuppressive drugs to manage critically ill patients has been widely disseminated and likely contributed to the increase in secondary infections and uncontrolled glycemic status1,2. The SARS-CoV2 virus can directly infect T cells and make patients susceptible to secondary infections and severe COVID-19 infection3 . Among fungal infections, cases of invasive pulmonary aspergillosis, invasive candidiasis, and pneumocystis have been described2-4. Here we report a fatal case of rhino-orbito-cerebral mucormycosis in a patient with uncontrolled diabetes after a COVID-19 infection.
dc.formatapplication/pdf
dc.languageeng
dc.rightsopen access
dc.subjectCOVID-19
dc.subjectSARS-CoV-2 virus
dc.titleFatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19
dc.typeArticle


Este ítem pertenece a la siguiente institución